Suzanoâs Deleveraging Progress Improves, but Buybacks and One-Off Effects Keep Investors Cautious
Suzanoâs Deleveraging Progress Improves, but Buybacks and One-Off Effects Keep Investors Cautious
Suzano S.A., the Brazilian pulp and paper giant, is showing signs of financial improvement as its deleveraging process continues. However, investors are still watching closely because share buybacks, non-recurring effects, and acquisition-related spending may slow the pace of balance-sheet repair.
The latest market discussion follows a Seeking Alpha analysis titled âSuzano: Deleveraging Progress Is OK, Ignoring The Buyback And Some Non-Recurring Effectsâ, which argued that the companyâs debt reduction is moving in the right direction, though not as quickly as some investors may prefer.
Debt Levels Remain the Main Focus
According to Suzanoâs first-quarter 2026 earnings release, net debt stood at R$68.1 billion, or around US$13.0 billion, at the end of March 2026. The companyâs leverage ratio was about 3.2 times adjusted EBITDA in Brazilian reais and 3.3 times in U.S. dollars.
This means Suzano is still carrying a large debt load, but the situation is not alarming if pulp prices, cash generation, and capital spending remain under control. The company has benefited from stronger pulp volumes, better pricing in some markets, and the gradual contribution of its major Cerrado project.
Operations Support the Deleveraging Story
Suzano remains the worldâs largest pulp producer and one of the biggest paper producers in Latin America. Its products are sold in more than 100 countries, giving the company broad exposure to global demand for tissue, packaging, paper, and bio-based materials.
In Q1 2026, the companyâs pulp business showed strength, supported by higher volumes and improved prices. Reports from the companyâs earnings call noted that pulp EBITDA reached about R$4.1 billion, although the paper and packaging segment faced pressure from lower export prices and currency effects.
Buybacks Complicate the Picture
One concern is that share buybacks can reduce the speed of deleveraging. Buybacks may benefit shareholders by reducing the number of shares outstanding, but they also use cash that could otherwise lower debt.
For a company with Suzanoâs leverage profile, investors often prefer a careful balance. Returning capital is positive when cash flow is strong, but debt reduction may deserve priority while leverage remains above more comfortable levels.
Non-Recurring Effects Need Careful Review
Another key issue is the use of add-backs and non-recurring adjustments. These can make earnings and leverage look better if the items truly will not repeat. However, investors usually become cautious when âone-offâ costs happen often.
In Suzanoâs case, maintenance events, ramp-up effects, currency movements, and other temporary factors can affect production, costs, and reported earnings. The important question is whether these issues fade over the next few quarters.
Kimberly-Clark Deal Adds Strategic Opportunity and Financial Pressure
Suzano is also pursuing growth through its deal with Kimberly-Clarkâs international tissue business. Reuters reported that the European Union approved Suzanoâs proposed $3.4 billion joint venture deal, under which Suzano would acquire a 51% stake in Kimberly-Clarkâs international tissue business.
This deal could help Suzano expand into consumer tissue markets and reduce dependence on pulp cycles. Still, it may also increase financial demands at a time when deleveraging remains an important investor priority.
Investor Outlook
The current investment case for Suzano depends on three main factors: pulp price stability, disciplined capital allocation, and steady debt reduction. If pulp markets remain healthy and Cerrado continues to improve efficiency, Suzano could generate strong free cash flow.
However, if buybacks, acquisitions, or repeated non-recurring costs consume too much cash, deleveraging may remain slower than expected. For that reason, the stock may appeal most to investors who believe in Suzanoâs long-term cost advantage but are willing to wait for clearer balance-sheet improvement.
Conclusion
Suzanoâs deleveraging progress is real, but not yet perfect. The company has strong assets, global scale, and improving operational momentum. At the same time, investors should not ignore the impact of buybacks, acquisition spending, and one-off adjustments.
The story remains cautiously positive: Suzano is moving in the right direction, but the market will likely demand more proof that cash flow can consistently reduce leverage while still supporting future growth.
#SlimScan #GrowthStocks #CANSLIM